Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$98.98 - $115.74 $26,724 - $31,249
270 Added 11.32%
2,656 $307,000
Q2 2023

Aug 08, 2023

SELL
$96.34 - $112.38 $963 - $1,123
-10 Reduced 0.42%
2,386 $245,000
Q1 2023

Apr 24, 2023

SELL
$107.32 - $113.5 $1,073 - $1,135
-10 Reduced 0.42%
2,396 $261,000
Q4 2022

Jan 17, 2023

BUY
$62.39 - $113.8 $150,110 - $273,802
2,406 New
2,406 $0

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Sequoia Financial Advisors, LLC Portfolio

Follow Sequoia Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.